Superworth

Insulet PE ratio PODD

Share price divided by earnings per share over the last twelve months, since 2019.

Today, Nov 2, 2026
28.7×
8-year median
62.7×
Against its 8-year history
7th
percentile: 0 is its lowest day, 100 its highest
8-year range
24.6× to 484×
Peer median
25.0×

Insulet's PE ratio is 28.7× as of Nov 2, 2026: a share price of $153.61 against $5.35 of earnings per share over the last twelve months.

That is below its 8-year median of 62.7×, lower than on 93% of days in the last 8 years.

Over that time it ranged from 24.6× in Oct 2026 to 484× in Jun 2019.

The median for 10 medical instruments and supplies stocks of a similar size is 25.0×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far28.7×24.6×84.5×
202584.4×42.6×107×
202447.1×34.4×120×
2023127×90.7×253×
2022454×315×475×
2021n/m a value too high to mean anything
2020n/m a value too high to mean anything
2019484×420×484×

Against its peers

Companies in Medical - Instruments & Supplies nearest Insulet's size, closest first, today.

CompanyPE ratio
PODDInsulet28.7×
GMEDGlobus Medical20.3×
ALGNAlign Technology26.8×
COOCooper Companies20.9×
PENPenumbra79.0×
SOLVSolventum10.4×
MSAMSA Safety23.2×
HAEHaemonetics58.9×
MMSIMerit Medical Systems31.7×
VNTVontier15.3×
BMIBadger Meter36.4×
Peer median25.0×

Where Insulet ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Insulet

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.